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ABSTRACT
Today the majority of females fifteen years and older
have used tampons.

Since their introduction in 1933,

tampons have changed greatly in composition:

more

absorbent synthetic fibers have replaced natural fibers,
plastic applicators have joined cardboard, and some contain
a fragrance.

While changes in vaginal mucosa including

inflammatory changes, lacerations, and micro-ulcerations as
a result of tampon use have been documented, no research
examining the use of menstrual hygiene products and their
effect on cervical cytology was located.
The purpose of this study was to examine the
association between menstrual hygiene product use and the
incidence of abnormal Pap smear results, specifically that
of benign cellular inflammatory changes and/or atypical
squamous cell of undetermined significance (ASCUS).

The

Theory of Nursing as Human Science and Human Care as
proposed by Jean Watson (1979) was the theoretical
framework for this study.
Data were collected by chart audit review of 250
women, ages 14 to 36, who sought Pap smear screening at a
Midwestern family planning clinic.

IX

The data collection

instrument was designed by the researcher.

Data were

analyzed using the Statistical Package for the Social
Sciences (SPSS-X).
The association in Pap smear result by tampon
applicator use, analyzed using Pearson Chi square, was
. .
found to be statistically significant
(X2=18.53; df=4;
p=0.003).

The difference in Pap smear result by type of
2

tampon was also statistically significant (X =48.06; df=3;
p=0.000).

Reported use of plastic and/or deodorized tampon

use by those subjects with inflammatory changes and/or
ASCUS Pap results was three times that of those reporting
cardboard applicator, non-deodorized tampon or sanitary pad
use.

x

CHAPTER I
INTRODUCTION
The composition of tampons has changed greatly over
the past fifty years:

more absorbent synthetic fibers have

replaced natural fibers, plastic applicators have replaced
cardboard, and some contain a fragrance.

These changes

warrant new studies examining tampon use and the effects of
tampon use.

"Given the increasing use of this internal

device and the rapidity with which new products are
manufactured and marketed, medical practitioners should
know what products are used, how often, and for what
purposes" (Cibulka, 1985, p. 224).
In response to the use of tampons, vaginal mucosa has
been examined via colposcopy and tissue biopsy with results
varying from no observable changes to the identification of
micro-ulcerations (Friedman, 1981; Friedrich & Siegesmund,
1980).

No study exploring a relationship between tampon

use and abnormal cervical cytology (Papanicolaou smear) was
located.
History and Significance
Menstrual hygiene products.

Today the majority of

American females fifteen years and older have used
tampons, which accounts in part for the billions of tampons
1

2

used in a year.

First marketed in 1936, the original

tampons were made of 100% surgical cotton in a two part
cardboard applicator.

The plastic applicator tampon was

introduced in 1967, followed by the debut of the deodorant
tampon in 1971.
In the case of the plastic applicator, its four to six
cusps at the end of the inserter have been reported to
cause vaginal and cervical lacerations (Barrett, Bledsoe,
Greer, & Droegemueller, 1979; Collins, 1979).

The

deodorant tampon is not in any way medically beneficial and
may instead present a health hazard because the perfume may
irritate the vaginal mucosa and the cervix and disrupt the
normal flora of the vagina (Hasselbring, Greenwood, and
Castleman, 1987; Horos, 1975).

Perfume products,

demonstrated to cause irritation and inflammation when
added to sanitary pads (Fischer, 1973; Larsen, 1979), have
not been subject to study in tampons.
Cervical cytology report.

The cytological descriptive

diagnosis of interest is that of The Bethesda System (TBS;
Appendix A) atypical sguamous cells of undetermined
significance (ASCUS), an epithelial cell change
demonstrated by slight to moderate changes in nuclear size
and morphology (Davis, Hernandez, Davis, Miyasawa, 1987;
Montz, Monk, Fowler, Nguyen, 1992).

The diagnosis ASCUS is

limited to those cases in which cellular changes exceed
those attributable to benign, reactive processes, but fall
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short of a definitive diagnosis of squamous intraepithelial
lesion (Knapp, 1993).
An ASCUS Pap smear result should be further qualified,
when possible, as to whether a reactive or a
premalignant/malignant process is favored.

Reactive

cellular changes are associated with inflammation while
premalignant/malignant changes are associated with squamous
intraepithelial lesions.

Reported incidence rates of this

diagnosis for all women range from 1.6% to 19% (Davis et
al, 1987; DHHS, 1989; Gunn & Simpson 1992; Kaminski,
Stevens, & Wheelock 1989; Pearlstone, Grigsby, & Mutch,
1992).
The Bethesda System for reporting cervical cytology,
(commonly referred to as a Pap smear) provides a uniform
format and a standardized lexicon, but it does not include
guidelines for patient management based on TBS diagnosis.
The contributing experts to TBS acknowledged certain
unanswered questions exist regarding management of atypical
cells of undetermined significance (ASCUS) and squamous
intraepithelial lesion (SIL)
Clinical management.

(Koss, 1990).

Clinical management of patients

with ASCUS Pap test results is a subject of debate.

Some

consider these minimal changes benign and recommend
periodic repeat Pap smears at intervals ranging from three
to twelve months.

Others repeat the Pap smear immediately

and recommend colposcopy and tissue biopsy if the atypia
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persists (Davis et al, 1987; Kaminski et al, 1989; Montz et
al, 1992).
Nurse clinicians often manage and counsel patients
regarding abnormal Pap smear follow-up.

Upon receiving

word of her abnormal Pap smear result, a woman may express
anxiety which can be compounded by the questionable
etiology of the abnormality.

The nurse clinician should

provide information about causes, diagnostic implications,
recommendations for follow-up care, and attempt to
alleviate patients anxieties related to the abnormal result
(Lauver & Rubin, 1991).
It is common for the nurse clinician to recommend the
patient avoid plastic and/or deodorized tampons in the
interim period (commonly three to six months) between the
initial and repeat Pap smears.

Additional education

includes avoidance of coitus, douching, or vaginal
medications for 24-48 hours before the Pap appointment
(Schumaker, 1991).
The nurse clinician's recommendations are guided in
part by protocol and in part by the following principles;
(a) a healthy vagina is moist, self-cleansing and naturally
protective against disease and odor causing germs (Horos,
1975), (b) menstrual flow has no odor while in the vagina
and therefore a deodorant to mask odor is unnecessary
(Friedman, 1981), (c) contact with any chemical or foreign
object on the fragile vaginal mucosa and cervix can a cause
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irritation and inflammation (Fisher, 1973; Friedrich &
Siegesmund, 1980; Larsen, 1979), and (d) inflammation
stimulates cell division and thus increases the chance for
abnormal cell changes (Perez-Tamayo, 1985).
Purpose
The purpose of this study is to examine the
association between menstrual hygiene product use and the
incidence of Pap smear results of inflammation and/or
atypical squamous cells of undetermined significance
(ASCUS) in females between the ages of 14 and 36 years.
Research Question
This study will address the following question:
What is the association between menstrual hygiene
product use and the incidence of the Pap smear results of
benign cellular inflammatory changes and/or atypical
squamous cells of undetermined significance for females,
ages 14 to 36 years, seeking services in a family planning
setting?
Research Hypothesis
Among females ages 14 to 36 years with Pap smear
results of benign cellular inflammatory changes and/or
atypical squamous cells of undetermined significance,
reported use of plastic applicator and/or deodorized tampon
use will be greater than reported use of cardboard
applicator/non-deodorized and/or sanitary pads.

6

Theoretical Framework
Watson's (1979) Theory of Nursing as Human Science and
Human Care lends itself well to the family planning
setting.

In daily conversation about sexuality issues, the

nurse will draw on scientific principles and the ability to
demonstrate transpersonal care in order to communicate
about these historically taboo subjects (Delaney, Lupton, &
Toth, 1976).

Communication is key to providing optimal

care, counsel and education in this nursing setting.
Person is viewed as a "being-in-the-worldM (Watson,
1985, p. 54-55); the three spheres of 'being'--the mind,
body and soul— are influenced by the concept of 'self'.
The 'self' is the "subjective center that experiences and
lives within the sum total of body parts, thoughts,
sensations, desires, memories, life history and so forth".
The concept of self is central to the family planning nurse
in empowering the client's decision making for her 'self'.
Environment consists of an internal and an external
environment.

The internal environment is that of mental

and spiritual well-being and sociocultural beliefs.

The

external environment includes the variables of comfort,
stress, privacy, safety, cleanliness and aesthetics
(Watson, 1979).

Choice of menstrual hygiene product and

feelings related to a female's menstrual cycle are integral
to the internal and external environments as described by
Watson.
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Health is an elusive, relative concept and is
individually defined.

It is, Watson (1979, p. 219) states,

:he "process of adapting, coping and growing that goes on
:rom conception to death".
Nursing is a "therapeutic interpersonal process"
(Watson, 1979, p. 7).

Nursing is involved with the

restoration, maintenance, and promotion of health and
prevention of illness.

Watson speaks of nursing as an art

and a science, more specifically a human science.
The structure for studying and understanding nursing
as a science of caring is formed by Watson's ten carative
factors (Watson, 1979, pp. 9-10).
significance for this study.
1.

Two factors have

They are as follow:

Carative Factor 6:

The systematic use of

the scientific problem-solving method for
decision making; and
2.

Carative Factor 7:

The promotion of

interpersonal teaching-learning.
The family planning nurse will gather data from the
client, i. e., Pap smear, menstrual history, psycho-sexual
history, and menstrual hygiene practices.

Applying the

scientific problem solving method, the nurse will examine
the association between the use of plastic applicator
and/or deodorant tampons and the incidence of ASCUS Pap
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smears.

Abnormal Pap smear follow-up counsel and education

will, in part, reflect the findings of this study.
Definitions
The following terms have been defined for the purposes
of this study:
Papanicolaou (Pap) smear consists of a sample of cells
from the epithelial surfaces of the uterine cervix placed
on a microscope slide, stained and studied under a
microscope by a cytopathologist or cytotechnologist.

It is

a simple screening tool for cervical neoplasia and other
abnormalities (Koss, 1990).

This specimen is also called a

cervical cytological smear.
Abnormal Pap smear includes only those Pap smear
results with either reported benign cellular inflammatory
changes or the TBS descriptive diagnosis of atypical
squamous cells of undetermined significance (ASCUS).
Previously this abnormal finding was classified as a Class
II Pap smear based on the Papanicolaou Classification
System (see Appendix B).
Tampon refers to a plug made of cotton and/or
synthetic fibers introduced into the vagina typically to
absorb menstrual flow.

The term "type of applicator"

refers to plastic, cardboard or non-applicator tampons.
The term "type of tampon" refers to deodorized or
non-deodorized tampons.
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Cardboard applicator refers to a tampon contained
within a cardboard applicator.
Plastic applicator tampon refers to a tampon contained
within a plastic applicator intended to ease insertion.
Deodorant tampon refers to a tampon containing a
fragrance intended to mask odor of menstrual flow.
Adolescent Onset (AO) appears on the data collection
instrument and refers to age at initiation of sexual
intercourse; in this case, prior to the age of 19 years.
Birth control method (BCM) appears on the data
collection instrument and refers to any intervention
including hormonal, barrier, or fertility awareness, used
to control a woman's fertility.
Multiple Contacts (MC) appears on the data collection
instrument and refers to number of lifetime sexual
partners; in this case, greater than one sexual partner in
preceding seven years.
Sexually Active (SA) appears on the data collection
instrument.

The frequency of sexual activity will be

described as frequent:

greater or equal to two acts of

intercourse per week or infrequent: less than two acts of
intercourse per week.
Limitations
Generalizability of findings may be limited due to
self-selection of patients served at this family planning
clinic.

CHAPTER II

REVIEW OF LITERATURE
This review of selected references will provide
background information on cervical cytology specifically
the Papanicolaou smear (Pap smear), its reporting system,
previously identified predictors of abnormal cervical
cytology, and menstrual hygiene products with emphasis on
tampons.
Cervical Cytologic Smear Reporting System
The cervical/vaginal cytologic smear, commonly known
as a Pap smear, was first introduced in 1943 by Dr. George
Papanicolaou, hence its name.

Cell samples, obtained from

the cervix and vagina, are stained by the Papanicolaou
method, microscopically examined, and interpreted by a
cytopathologist.

The screening test is largely responsible

for the 70% decrease in morbidity and mortality resulting
from cervical cancer over the past forty years (Koss, 1990;
Lundberg, 1989; U. S. DHHS, 1989).

The Pap smear is

simple, painless and "one of the most accurate and cost
effective medical tests" (DHHS, p. 3).
Papanicolaou classification system.

According to Koss

(1990 p. 988), Papanicolaou recognized "that he was not
qualified to render diagnostic verdicts based on the
10
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smear".

Thus, he devised a five class system of reporting

Pap smear results (Appendix B).

This system has been

widely accepted in the United States; however, laboratories
may differ in the way in which they use the system's
terminology.

These variations may significantly alter the

clinical implications of the Pap smear report.

Recent

controversy regarding the Pap system of reporting, its
varied and sometimes ambiguous terminology, and quality
assurance are reflected in the literature (Koss, 1989;
Lundberg, 1989) .
The Bethesda System.

Under the auspices of the

National Cancer Institute, a multidisciplinary group of
experts convened in Bethesda, Maryland, in December of
1988.

The purpose of the meeting was to address the

standardization of cervical/vaginal cytology reports.

The

resulting system, The Bethesda System was adopted by
consensus and gained widespread support in laboratory
practice.

TBS offers a uniform format and provides a

standardized lexicon for cervical cytology reports,
specifically emphasizing communication of clinically
relevant information (Knapp, 1993).
Re-evaluation and revisions to TBS were made when the
group reconvened in 1991.

While TBS does not include

guidelines for patient management, the desire for such
guidelines was emphasized at this second meeting.

The

contributors called for additional research and clinical
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trials to resolve certain unanswered questions regarding
management of ASCUS and low grade lesions (Knapp, 1993).
Predictors of Abnormal Cervical Cytology
Sexual factors.

Various indicators of sexual activity

have long been known to be associated with cervical cancer,
and a large number of epidemiological studies have been
carried out on this subject.

Studies indicate that age at

first intercourse, multiple sexual partners, and having a
male partner with multiple partners are associated with the
risk of developing cervical cancer.

This has prompted a

search for one or more sexually transmitted diseases (STDs)
which play a role in the pathogenesis of cervical cell
abnormalities (Berger, 1978; Buckley, Doll, Harris, 1981;
Clarke, Hatcher, McKeon-Eyssen, 1985; Montz, Monk, Fowler,
Nguyen, 1992; Slattery, Overall, Abbott, French, Robison, &
Garner, 1989; Vessey & Williams, 1981; Wright & Riopel,
1984; Wynder, 1969).
Contraceptives.

Several epidemiological studies of

the relationship between oral contraceptives (OC) and
cervical neoplasia have yielded conflicting results.

This

may be in part due to the fact that OC use is strongly
correlated with the aforementioned key sexual risk factors
and the degree of adjustment for these confounding
variables among studies (Brinton, et al., 1986; Clarke,
Hatcher, McKeown-Eyssen, & Lickrish, 1985; Irwin, et al.,
1988).
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If an STD is the major cause of cervical cancer, a
protective effect of barrier contraception should be
expected.

Spermicides and condoms may be protective

(Celentano, Klassen, Weisman, & Rosenhein, 1987), while the
cervical cap may actually increase the risk of cervical
cell abnormalities (Berstein, 1986).
Smoking.

An association between cigarette smoking and

cervical cancer was first proposed over 15 years ago.
Recent studies revealed an approximately two-fold increase
in risk for smokers versus non-smokers, and a clear
dose-response relationship was observed in two of these
studies (Brinton, Schairer, Haenszel, Stolley, Lehman,
Levine, & Savitz, 1986; Clark, Hatcher, McKeown-Eyssen, &
Lickrish, 1985; Mitchell, Sandeila & White, 1992; and
Trevathan et al., 1983).
Tampons
Historical perspective.

Although "invented" in 1933

by an American physician, documentation of tampon use by
women dates back to the fifteenth century B.C.
composition varied among cultures.

Tampon

Roman women used soft

wool; Egyptian women, papyrus; Japanese women chose paper;
and women of African and Asian cultures used a variety of
plants to construct internal vaginal guards to be worn
during menstruation (Delaney, Lupton, & Toth, 1976, ;
Friedman, 1981).
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The first tampons to be marketed in the United States
were made of 100% cotton; most were compressed within a two
part cardboard applicator.

By the 1970s, rayon was

combined with or replaced cotton in nearly every tampon on
the market.

The tampons of today are made of combinations

of rayon and synthetic fibers, and can be purchased with a
cardboard or plastic applicator, or with no applicator at
all.

(Delaney et al., 1976, 198.8; Friedman, 1981, Friefeld,

1984).

Fragrance first appeared in tampons in 1971.

The

intent was that American women could have a the combination
of a "soft and gentle" tampon with a "fresh, delicate
scent" (Friedman, 1981, p. 51).

A perfumed product was,

and still is, promoted as a deodorant product.
Tampons were classified by the Food and Drug
Administration (FDA) as a cosmetic from 1938 to 1968.

As a

cosmetic, tampons were considered outside the realm of
federal regulation.

In 1968, tampons became a Class I

medical device, and in 1980 were reclassified as a Class II
medical device, thereby subject to FDA performance
standards, if and when such standards are developed.
Cibulka (1983) reports consumer groups are advocating the
change from a Class II to a Class III medical device.

This

change would subject tampons to rigorous pre-market testing
for effectiveness and safety.
In 1982, the FDA required tampon manufacturers to
include standardized warning labels and package inserts
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advising consumers of the risks and symptoms of Toxic Shock
Syndrome (TSS), a rare but sometimes fatal disease
associated with tampon use.

The FDA also recommended those

women using tampons use the least absorbent tampon
necessary for absorption of menstrual flow. (Consumer
Reports, 1986; Friefeld, 1984; Nightingale, 1990).
FDA testing demonstrated that terms used to signify
absorbency such as "regular" and "super" varied in meaning
among tampon manufacturers.

As a result of the findings,

the FDA ruled that beginning March 1, 1990, the following
terms would be uniform among tampon manufacturers and were
to appear on package labeling:

junior (6 grams or less of

fluid absorbed per tampon; regular (6 to 9 grams); super (9
to 12 grams); and super plus (12 to 15 grams)
Reports, 1986, 1990; Nightingale, 1990).

(Consumer

Tampon

manufacturers are not required to list ingredients,
including composition of fibers or perfume additives, at
this time.
Composition.

Prior to 1977, tampons were made of

cotton, rayon, or a combination of the two.

Since then,

the composition of tampons has changed to include more
absorbent synthetic materials.

In some tampon users this

increased absorbency has been detrimental.

Extensive

research supports the association between absorbency and an
increased risk for TSS.

Toxin producing Staphylococcus

aureus and tampon use have been implicated as causative
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factors in the development of TSS; the exact nature of the
relationship is not yet clearly understood (Cibulka, 1983;
Consumer Reports, 1986; Finkelstein & Von Eye, 1990;
Friefeld, 1984; Irwin & Millstein, 1982; Nightingale,
1990).
Perfume was added to tampons in 1971 and the product
was designated a deodorant (not scented) tampon (Friedman,
1981; Larsen, 1979).

Fisher (1973) reported that several

documented cases of irritation and dermatitis secondary to
use of perfumed feminine hygiene sprays appear in the
literature.

Larsen documents the occurrence of vulvar

dermatitis which was a result of the perfume in a deodorant
sanitary napkin.
Absorbency.

The concept of absorbency is the focus of

several reports on tampons.

Early researchers regarded

absorbency in terms of "complete protection" (Arnold and
Hegele, 1938, p. 792) or the ability of a tampon to absorb
the menstrual flow without the additional use of a sanitary
napkin.

The studies of Arnold and Hegele and Thornton

(1943) suggest that early tampons, made of cotton fibers,
did not afford complete protection for the majority of
women using them. •Based on their limited knowledge of how
susceptible the vaginal mucosa was to repeated irritation,
the early researchers concluded that "when tampons are used

17

regularly during the menstrual period, periodic examination
of the vagina should be made to ascertain whether the
mucosa remains normal" (Arnold & Hegele, 1938, p. 791).
Friedrich and Siegesmund (1980) examined absorbency of
tampons in relation to alterations in vaginal mucosa
revealed by colposcopic evaluation.

The researchers

conducted a blind, random study of one hundred and sixty
women using tampons either during periods or between
periods.

Tampons were identified as either

"superabsorbent" or "non-superabsorbent"; no deodorant
tampons were used.

The researchers concluded that

superabsorbent tampons are significantly more likely to
produce micro-ulcerations than non-superabsorbant tampons
when used intermenstrual.ly.

Furthermore, chronic

production of these alterations could lead to clinically
visible lesions of the vagina.
Safety and comfort.

Concepts of safety and comfort

are addressed in early literature about tampons.

Most

researchers reported in favor of tampon use and found that,
among their subjects, tampons were a generally safe,
comfortable, effective way of managing menstrual flow
(Arnold & Hegele, 1938; Barton, 1942; Dickinson, 1945;
Magid Sc Geiger, 1942 ; Thornton, 1943 ; Wheatley, Menkin,
Bardes, Sc Rock, 1965; Widenius, 1944).
Moral implications.

The use of tampons created a

moral dilemma for some, including clergy, physicians and
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consumers.

It was believed a tampon could possibly rupture

the vaginal hymen of a virginal woman thereby being an
agent of defloration (Barton, 1942; Singleton & Vanorden,
1943).

In 1945, Dr. Karnaky, who had conducted a five year

study of 42 women, declared the tampon safe for "unmarried
women" (Friedman, 1981, p. 45).

In a review paper,

Dickinson (1945, p. 490) explored and compared the
eroticism of the "internal and external menstrual guards".
Therapeutic use.

Researchers in the late 1950s and

early 1960s advocated the use of tampons in the treatment
of vaginitis (Friedman, 1981; Karnaky, 1956).

According to

Triedman, Karnaky also recommended tampon use as an aid in
managing infertility, but, he did not provide specific
support for this recommendation.

Rutherford, Banks and

Coburn (1962) advocated the therapeutic use of tampons in
postpartum lochia flow.

Lamb and Berg (1985) examined the

potential role of vaginal tampons in women with
endometriosis.
Injuries.

Several case studies describing the

incidence of tampon associated ulcerations and lacerations
appear in the literature (Barrett, Bledsoe, Greer, &
Droegemueller, 1977; Collins, 1979; Jimerson & Becker,
1980; Weissberg & Dodson, 1980).

Barrett et al. suggest

pressure necrosis or chemical irritation as the mechanism
of ulcer formation in the cases they reported.

Collins

(1979, p. 127) attributed a one to two millimeter tear
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which resulted in "a life threatening hemorrhage"

to the

cusp of a plastic inserter and asserted that foreign body
insertion is the major noncoital cause of vaginal injury".
Related variables.

The studies of Irwin and Millstein

(1982) and Finkelstein and Von Eye (1990) suggest that
physicians and nurses do not fully understand the
relationships of age, racial-ethnic differences, patterns
of sanitary product use, and the role they play in the
production of TSS.

The researchers encouraged further

study of sanitary product use with consideration of
additional variables including socioeconomic status.

CHAPTER III

METHODOLOGY
The purpose of this study was to describe the
association between menstrual hygiene product use and the
incidence of Pap smear results of inflammatory changes
and/or atypical squamous cells of undetermined
significance.

In this chapter the study sample,

methodology, and proposed data analysis will be described.
Population
The target population was females, ages 14 to 36
years, who use tampons during a menstrual period.

The

accessible population was that of females, ages 14 to 36
years, who sought services at a Midwestern family planning
clinic.
Study Design
The study was non-experimental in nature.

It was a

retrospective exploratory study of menstrual hygiene
product use and the resulting incidence of abnormal Pap
smear results.
Sampling method.

The sample group was 250 females,

who sought a Pap smear in the 6 month time period of
November, 1992 through April, 1993.

Subjects were selected

at random from the 1364 women whose names appeared in the
20
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clinic lab log.

Entries were numbered consecutively, and a

table of random numbers used to select cases for study.
Of the 400 charts selected 150 were excluded from the study
for the following reasons:
preceding 15 months,

abnormal Pap smear within the

(n=25; 7%); repeat Pap smear following

an abnormal (n=57; 38%); age (n=7; 5%); and incomplete data
base (n=61; 40%).

The remaining 250 charts were used in

data collection.
Protection of human subjects.

The study was in

compliance with the legal reguirements governing human
subjects research, as set forth by both the Institutional
Review Board and the Department of Health and Human
Services (Department of Health and Human Services 1990;
Institutional Review Board, 1989) .

This project was

subject to "exempt'1 review because it is a study of
existing data, documents or records.
Data Collection Method
Data were collected by chart audit review.

Responses

to questions regarding menstrual hygiene product use are
recorded in each client's chart as part of the health
history.

Data were located and transferred to the data

sheet described below.

Data collection began upon approval

from the Human Subjects Review Board and the participating
agency.
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Instrument
The data collection instrument was designed by the
researcher (Appendix C).

It included data related to age,

adolescent onset of sexual intercourse, history of multiple
sexual partners, frequency of sexual activity, birth
control method, menstrual hygiene product use, age at first
use, smoking status and the Pap smear result.
Data Analysis
The association between menstrual hygiene product use
and non-malignant Pap smear results was evaluated by
Pearson Chi square analysis of the cross classification of
the two factors (Kirk, 1990).

Separate analysis were

conducted for applicator type and deodorant presence in
tampons.

The overall Type I error rate (alpha) was set at

.05; Bonferroni's approach, was used to control the
experiment wise Type I error rate (Kirk, 1982), so the
nominal alpha was .025 for each test.

Other data were

analyzed using the Student's t-test and descriptive
statistics including means, standard deviations,
frequencies and percentages.

Chapter IV
RESULTS
In this chapter the findings of data analysis will be
presented.

The sample profile will be discussed followed

by the research question and hypothesis outcomes, and
additional findings of interest.

Data were analyzed using

the Statistical Package for the Social Sciences— Revised
(SPSS-X).
Sample Profile
The sample profile results are portrayed in Table 1.
The subjects ranged .in age from 14 to 36 years (X=22.2
years; N=250; SD=4.3).

Nearly three fourths of the females

reported adolescent onset of intercourse (n=185; 74%),
compared to 65 (26%) who had abstained until the age of 19
years.

Multiple sexual contacts were reported by 198 (79%)

respondents while 52 (21%) reported only one lifetime
sexual partner.

Eighty three (33%) respondents report

frequency of sexual intercourse to be less than two acts of
intercourse per week, while sixty one (25%) reported
intercourse occurred two or more times per week; missing
data (n=106; 42%).

The vast majority of females used oral

contraceptives as a birth control method (n=224; 90%),
while 11 (4%) used condoms, 2 (1%) used spermicides, 2 (1%)
23
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used diaphragms, and 11 (4%) relied on other birth control
methods (e. g. fertility awareness, sponge, sterilization,
withdrawal, and none).

Cigarette smoking was reported by

53 (21%) of the females; the remaining 197 (79%) were
non-smokers.
Tampon use was reported by 189 (76%; n=250) of the
females while 61 (24%) used sanitary pads only.

Age of

first use of tampons ranged from 9 to 21 years with a mean
of 14 years (SD=6.5; n=250).

With regard to tampon

applicator type 76 (27%) used plastic applicators, 88 (35%)
used cardboard applicators, 29 (12%) used either
applicator,

(2%) used non-applicator tampons.

With regard

to type of tampon the majority of females selected
non-deodorized tampons (n=131, 52%), compared to those who
used deodorized tampons (n=38; 15%), either type (n=20;
8%).

One hundred twenty five of the females reported using

0 to 4 tampons per day (50%) compared to 61 (24%) who used
5 ana 8 tampons per day, and 3 (1%) who used 9 to 12
tampons per day.
Sanitary pad use was reported by 221 (88%) of the
females compared to 29 (12%) who reported non-use of pads
(n=250).

Non-deodorant pads were used by the vast majority

(n=211; 84%).

Deodorant pads were used by 4 (2%) females

and 6 (2%) reported using either type of product.
Pap smear results of within normal limits (WNL) were
reported in 201 (80%) of the cases, compared with 30 (12%)
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ASCUS results, 4 (2%) LSIL results, 11 (4%) benign cellular
inflammatory changes, and 4 (2%) other results.

Combining

the Pap results of ASCUS and benign cellular inflammatory
changes, a total of 41 (16%) Pap results met the criteria
of the Pap results of interest.
Table 1
Sample Profile

n

Characteristic
Adolescent Onset of Intercourse
Yes

74

185

No

26

65

79

198

< 2 times/wk

33

83

> 2 times/wk

25

61

Missing Data

42

106

Multiple Contacts
Yes
No
Sexual Activity
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('Table 1. Sample Profile, continued)

Characteristic

%

II

90

224

Condom

4

11

Spermicide

1

2

Diaphragm

1

2

Natural Family Planning and Other

4

11

Plastic

27

67

Cardboard

35

88

Either

12

29

2

5

24

61

Deodorant

15

38

Non Deodorant

52

131

8

20

25

61

0-4

50

125

5-8

24

61

1

3

25

61

Birth Control Method
Oral Contraceptives

Applicator Type

Non Applicator
Non Use
Type of Tampon

Both
Non Use
Number of Tampons Used Per Day

9-12
Non Use
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fTable 1. Sample Profile, continued)

n

%

Characteristic
Pads

2

4

84

211

2

6

12

29

WNL

80

201

ASCUS

12

30

LSIL

2

4

INFLAM

4

11

Other

2

4

Yes

21

53

No

79

197

Deodorant
Non-Deodorant
Either
Non-Use
Pap Results

Smoker

Range

n

Mean

SD

Age

22.2

4.3

14-36 yrs

250

Age At First Tampon Use

14.6

1.9

9-21 yrs

250

Characteristic

N=2 50
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Examination of the Research Question and Hypothesis
The research question was:

What is the association

between the type of menstrual hygiene product used and the
incidence of the Pap smear results of benign cellular
inflammatory changes and/or atypical squamous cells of
undetermined significance for females, ages 14 to 16 years,
in a family planning setting?
The research hypothesis was:

Among females ages 14 to

36 years with Pap smear results of benign cellular
inflammatory changes and/or atypical squamous cells of
undetermined sig .ificance, reported use of plastic
applicator and/or deodorized tampons will be greater than
reported use of cardboard applicator/non-deodorized and/or
sanitary pads.
Eight cases were excluded in statistical analysis:
Pap results of low grade squamous intraepithelial lesions
(n=4; 2%) and Pap results of "other" (n=4; 2%).

Tables 2

and 3 list the cross-tabulation of abnormal Pap smear
results with applicator type and deodorant type,
respectively.

The research hypotheses regarding applicator

and deodorant type were supported from a statistical
perspective.

Pap smear results by type of applicator

(plastic, cardboard, non-applicator) used were
significantly different as noted by Pearson Chi square
results (X2=18.853; df=4; p=0.003; N=242).
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Pap smear results by deodorant type used were significantly
different (X2=48.06; df=3; p=0.000? N=242).
Among those subjects with abnormal Pap results (n=41)
reported use of plastic applicators (n=17; 41%) was nearly
three times that of use of cardboard applicators (n=6;
14%); and twice that of reported use of pads (n=9; 22%).
Furthermore, among these same subjects reported use of
deodorant tampons (n=17; 41%) was nearly three times that
of non-deodorant (n=6; 14.6%); and twice that of reported
use of pads (n=9; 15%).
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Table 2
Chi Square Pap Result By Menstrual Hygiene Product

Non-malignant Pap Results
Count
Row Pet
Col Pet
Normal

Abnormal

ROW
TOTAL

Applicator
Plastic

47
73.4
23.4

17
26.6
41.5

64
26.4

Cardboard

80
93.0
39.8

6
7.0
14.6

86
35.5

Either

19
67.9
9.5

9
32.1
22.0

28
11.6

Non-Applicator

Non-Use
(pads)
COLUMN
TOTAL

4
100.0
2.0

-

51
85.0
25.4

9
15.0
22.0

60
24.8

201
83.1

41
16.9

242
100.0

Value
Pearson Chi Square

4
1.7

15.9

df
4

E
0.003
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Table 3
Chi Square Pap Result Differences By Type Of Tampon

Non-malignant Pap Results
Count
Row Pet
Col Pet

ROW
TOTAL

0
Normal

1
Abnormal

Deodorant

20
54.1
10.0

17
45.9
41.5

37
15.3

Non-Deodorant

120
95.2
59.7

6
4.8
14.6

126
52.1

Either

10
52.6
5.0

9
47.4
22.0

19
7.9

Non-Use

51
85.0
25.4

9
15.0
22.0

60
24.8

201
83.1

41
16.9

242
100.0

Tampon type

COLUMN
TOTAL

Pearson Chi Square

Value

df

48.06

3

E
0.0000

Additional Findings
Incidence of abnormal Pap smears is significantly
greater in those who experienced initial intercourse during
adolescence (X2=4.32; df=l; p=0.037; N=242).
presents these results.

Table 4
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Table 4
Chi Square Pap Result Differences By Adolescent Onset Of

Intercourse
Non-malignant Pap Results
Count
Row Pet
Col Pet

1
Abnormal

0
Norma]

AdolesuenL Onset.
Of Intercourse

ROW
TOTAL

Yes

154
86.0
76.6

25
14.0
61.0

179
74.0

No

47
74.6
23.4

16
25.4
39.0

63
26.0

201
83.1

41
16.9

242
100.0

COLUMN
TOTAL

Value
Pearson Chi Square

4.33*

df
1

*p < 0.05

Student t-tests of Pap by age and Pap by age at first
use were calculated.

The mean age of the two groups,

normal and abnormal Pap results, differed significantly
(t=-2.05; df=240; p=0.04).

Table 5 presents the results.

T-test for age at first use was non-significant.
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Table 5

Students t-test Of Mean Age By Pap Result

N

Mean

SD

201

21.9

4.3

t

df

P

Age

Group 1
(Normal Pap)

-2.05
Group 2

41

23.4

240

0.04

4.5

(Abnormal Pap)

When Chi square was used to determine differences in
Pap results by the following variables there were no
significant differences:

multiple sexual contacts,

(X2=3.67; df=l; p=NS; N=242); frequency of sexual
intercourse (X2 =1.58; df=2; p=NS); birth control method
2

(X =2.39; df=5; p=NS); number of tampons used per day
(X£'=2.2 0 ; df =3) ; use of pads (X2=2.49; df=3 ; p=NS) ; and
.
2
smoking status (X =1.09; df=l; p=NS).

CHAPTER V

DISCUSSION
This chapter will provide a brief summary of the
study.

Discussion and conclusions will be presented

followed by recommendations for practice, education,
research and policy.
Summary
Today the majority of females fifteen years and older
have used tampons.

Since their introduction in 1933,

tampons have changed greatly in composition:

more

absorbent synthetic fibers have replaced natural fibers,
plastic applicators have joined cardboard, and some contain
a fragrance.

While changes in vaginal mucosa including

inflammatory changes, lacerations, and micro-ulcerations as
a result of tampon use have been documented, no research
examining the use of menstrual hygiene products and their
effect on cervical cytology was located.
The purpose of this study was to examine the
association between menstrual hygiene product use and the
incidence of abnormal Pap smear results.

The Pap smear

result of interest was that of benign cellular inflammatory
changes and/or atypical squamous cell of undetermined
significance (ASCUS).
34
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Data were collected by chart audit review of 250
women, ages 14 to 36, who sought Pap smear screening at a
Midwestern family planning clinic.

The data collection

instrument was designed by the researcher.

Data were

analyzed using the Statistical Package for the Social
Sciences (SPSS-X).
The association in Pap smear result by tampon
applicator use, analyzed using Pearson Chi square, was
2

found to be statistically significant (X =18.53; df=4;
p=0.003).

The difference in Pap smear result by type of
2

tampon was also statistically significant (X =48.06; df=3;
p=0.000).
Discussion
Review of the literature.

The current literature

suggests that ASCUS Pap smears occur at a frequency of 1.6
to 19% (Davis et al,; 1987; DHHS, 1989; Gunn & Simpson,
1992; Kaminski et al., 1989; Pearlstone et al., 1992).

The

study results indicate an incidence rate of 12% and thus
remain consistent with previously documented incidence
rates.
While risk factors for benign cellular changes and
atypia have not been extensively studied or reported in the
literature, those for cervical cancer have been identified.
Among factors identified as altering risk for cancer are
those related to age, sexual behavior, contraceptive
methods, and cigarette smoking (Berger, 1978; Brinton et
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al., 1986; Celentano, Klassen, Weisman, & Rosenhein, 1987;
Clarke et al., 1985; Irwin, 1988; Trevathan, 1983).
The results of this study indicate type of tampon
(deodorant, non-deodorant) and type of applicator
(plastic, cardboard, non-applicator) were associated with
the increased possibility of an abnormal Pap result of
benign cellular inflammatory changes and/or ASCUS.

This

finding is consistent with principles of vaginal health:
contact with any chemical or foreign object on the fragile
mucosa can cause irritation and inflammation (Fisher, 1973;
Friedrich & Siegesmund, 1980; Larson, 1979), and
inflammation stimulates cell division thereby increasing
the chance for abnormal cell changes (Perez-Tamayo, 1985).
The results of this study support the findings that
adolescent onset of sexual intercourse is associated with
an increased likelihood of an abnormal Pap smear result
(see Table 4).

A Student's t-test was significant for the

relationship between age and Pap smear result (see Table
5) .
In this study, results indicate the differences
between history of multiple sexual contacts, birth control
method, and smoking status by Pap smear result are
determined to be non-significant.

The results do not

support previously evidenced associations; however these
other studies reviewed malignant findings while this study
reviewed non-malignant Pap results.
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A survey of the literature reveals a limited number of
articles regarding tampon usage with the exception of those
which are directly related to TSS.

From 1938 to 1966,

articles in the medical literature debated clinical and
moral issues involving tampon use.

Researchers concluded

that tampons were a safe and effective means for the
absorption of menstrual fluid (Arnold & Hegele, 1938;
Barton, 1942; Dickinson, 1945; Karnaky, 1956; Rutherford et
al., 1962; Thornton, 1943; Widenius, 1944).

When it was

discovered, in the late 1950s, that the deep vaginal mucosa
lacked any specific nerve endings, the focus on tampons and
its implications for morality diminished (Wheatley et al.,
1965).

The literature review revealed no documented

studies of tampons usage in the medical literature from
1966 to 1977.
The literature of the late 1970's and early 1980s
evidenced a growing concern for the incidence of
tampon-induced lacerations and ulcerations.

However, this

concern was overshadowed in July, 1980, by the newly
diagnosed, tampon-associated Toxic Shock Syndrome.
Why the dearth of information regarding such a common
practice such as tampon use in menstruating females?

No

doubt, the low social status of women in times past, and
the taboos, myths, and superstitions, which even now,
surround menstruation have been important factors.
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Theoretical framework.

The Theory of Nursing as Human

Science and Human Care as proposed by Jean Watson (1979)
provided the theoretical framework for this study.

In

daily conversation about sexuality issues the nurse draws
on scientific principles and the ability to demonstrate
transpersonal care in order to communicate about these
historically taboo subjects.

Two of Watson's ten Carative

Factors--Carative Factor 6: the systematic use of the
scientific problem-solving method for decision making? and
Carative Factor 7:

the promotion of interpersonal teaching

and learning had significance for this study.

Applying the

scientific problem solving method, the researcher examined
the association between the use of menstrual hygiene
products and incidence of abnormal Pap smear results.

The

process provided the opportunity to be engaged in the
interpersonal teaching and learning process with
professors, co-workers, and clients
Implications for practice.

The nurse clinician's role

in cervical cytology screening and the prevention,
detection, and follow-up care of abnormal Pap smears
includes the responsibilities of patient education,
consultation, and consumer advocacy.

The nurse's

responsibilities require expertise in detection skills,
quality assurance and control, the maintenance of a
therapeutic environment for learning, and ongoing critical
analysis of potential causal relationships that can alter
Pap smear findings.
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Patient education is guided in part by protocol and
ased on principles of vaginal health.

The nurse clinician

ust provide an explanation of the reason for Pap screening
nd evaluate the learning needs of the patient regarding
isk behaviors.

The nurse should recognize and attempt to

iminish the patient's negative emotions regarding the Pap
mear result.
Consultation involves nurses in collaboration with
hysicians, cytopathologists, and cytotechnologists (list
ot exclusive) performing periodic review of patient
istories and identification of high risk factors,
ducation on methods, materials, and considerations for
sliable Pap screening are necessary.

Ginsberg (1991)

uggests standardized educational protocols for health care
roviders to encourage uniform Pap screening are warranted.
Nurses as consumer advocates for health must
antribute to the establishment of standardized protocols
ar abnormal Pap smear management.

Nurses can promote

anfidence in Pap smear screening by educating the
ammunity via newspaper, public service announcements, and
gencies who serve women.

Nurses can join with consumer

roups to urge tampon manufacturers to list ingredients;
tie Menstrual Wealth Catalog (1993) reports incidence of
axes, surfactants, alcohols, acids, nitrogen compounds,
nd hydrocarbons being leached from tampons and pads.

As

dvocates for women's health, nurses must increase self and
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other awareness about the potential damage to the
environment resulting from the disposal of plastic and
paper menstrual hygiene products, approximated to be 11.5
billion pounds per year (Menstrual Wealth Catalog, 1993).
Basic nursing curricula need to include content on
eliciting a complete psycho/social/gynecologicc.l history.
A complete history should include, but not be limited to,
information regarding sexual behavior, contraception,
smoking status, menstrual history, and feminine hygiene
practices including use of menstrual hygiene products and
douching.

Furthermore, nurses should be aware of the

potential risks associated with these components of the
patient history.
Recommendations for Further Research
Replicating this study using a larger sample, or a
continuation of this presented study, to strengthen the
generalizability of the results would be useful.

For ease

in data collection, the data regarding menstrual hygiene
product use could be incorporated into the cervical
cytology lab slip submitted with the specimen.
A longitudinal study of females with ASCUS Pap results
could examine the frequency in which atypia persisted or
recurred over time with consideration for
continued/discontinued use of a specific menstrual hygiene

41

product.

Concurrently, the natural history of the

cytological changes could be examined.
A survey could be undertaken to determine female's
reasons for choosing particular menstrual hygiene products,
feelings about menstruation and the need for such products,
and patient identified concerns regarding use of such
products.

Given the prevalence of use of tampons and the

rapidity with which new products are introduced, nurse
clinicians should know what products are used, how often,
for what purposes, and at what risks or benefits to women's
health.

APPENDICES

APPENDIX A

THE BETHESDA SYSTEM FOR
REPORTING OF CERVICAL CYTOLOGICAL SMEARS
The cytopathologist's cervical smear report will
include information regarding the following:
Specimen Adequacy:
satisfactory,
unsatisfactory
less than optimal, limited by;
General Categorization of specimen:
within normal limits
unsatisfactory
Descriptive Diagnosis
infection
reactive and reparative changes
epithelial abnormalities
squamous cell
glandular cell
non-epithelial malignant neoplasm:
hormonal evaluation (vaginal smears)
other
Recommendations
(Koss, 1;'90)
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APPENDIX B

THE PAPANICOLAOU CLASSIFICATION SYSTEM
Class 0

few cells; white blood cells, red
blood cells, dried; distorted cells
broken slide

Class I

Normal, differential cells, metaplasia
mild inflammation.(Normal)
Histology: Normal,
Squamous metaplasia

Class II
or III

Less than 10% basal or
undifferentiated cells
Histology: Atypical Squamous cells

Class III

10-20% Basal or undifferentiated
cells
Histology: Moderate Dysplasia

Class IV

Greater than 30% Basal or
undifferentiated cells on slide
Histology: Severe dysplasia
Carcinoma in situ

Class V

Malignant cells
Histology: invasive cancer
(DHHS, 1989).
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